4Li J, Qu X, Bertram JF. Endothelial-myofibroblast transition con- tributes to the early development of diabetic renal interstitial fi- brosis in streptozotocin-indueed diabetic mice[J]. AmJ Pathol, 2009,175 : 1380.
5Niksie L,Martin PY. [BMP-7 (Bone morphogenetic protein-7) :a future treatment for chronic renal failure[J]? Rev Med Suisse, 2005,1 (8) :568.
6Yamaguchi Y, Iwano M, Suzuki D, et a l. Epithelial-mesenehymal transition as an explanation for pedocyte depletion in diabetic- nephmpathy[J]. Am J KidneyDis, 2009,54(4) : 653.
7Liu Y. Epithelial to mesenchymal transition in renal fibrogenesis: Pathologic signifi-cance, molecular mechanism, and thera-peutic intervention[J]. J Am Soc Nephrol , 2004,15 : 1.
8Claire E Hills,Paul E Squires. TGFβ1-induced Epithelial-to-Mes- enchymal Transition and Therapeutic Intervention in Diabetic Nephropathy~J~. Am J Nephrol. 2010,31 (1) : 68.
9Dudley AT , Lyons KM ,Robertson EJ. A requirement for bone morphogenetic protein -7 during development of the mammalian kidney and eye[J]. Gene Dev, 1995,9 (22) : 2795.
10Morrissey J, Hruska K, Guo G, et al. Bone morphogenetie pro- tein-7 improves renal fibrosis and accelerates the return of renal function[J]. J Am Soc Nephrol, 2002,13 (Suppl) : S14.
